IFIH1 and dermatomyositis: In patients with dermatomyositis (DM)-associated interstitial lung disease (ILD) combined with anti-melanoma differentiation-associated protein 5 antibody (MDA5), compared with myositis-specific antibody-negative patients without ILD (DM-nonILD - msa16(-)) and normal human controls (HC), hsa- miR-4488 was significantly upregulated and hsa-miR-1228-5P was upregulated in DM-ILD-MDA5 Ab(+) and downregulated in DM-nonILD-MSA16(-) compared to HC (121).